These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


107 related items for PubMed ID: 1164156

  • 21. [Influence of beclomethasone dipropionate on rabbit's nasal mucosa, adrenal and frog oral mucociliary activities].
    Li Y.
    Zhonghua Er Bi Yan Hou Ke Za Zhi; 1991; 26(3):135-7, 188. PubMed ID: 1888534
    [Abstract] [Full Text] [Related]

  • 22. [The tolerability of nasal drugs with special regard to preservatives and physico-chemical parameters].
    Verse T, Sikora C, Rudolph P, Klöcker N.
    Laryngorhinootologie; 2003 Nov; 82(11):782-9. PubMed ID: 14634896
    [Abstract] [Full Text] [Related]

  • 23. Effects of benzalkonium chloride on innate immunity physiology of the human nasal mucosa in vivo.
    Storaas T, Andersson M, Persson CG, Steinsvåg SK, Marko-Varga G, Greiff L.
    Laryngoscope; 2000 Sep; 110(9):1543-7. PubMed ID: 10983958
    [Abstract] [Full Text] [Related]

  • 24. Effects of preservatives in nasal formulations on the mucosal integrity: an electron microscopic study.
    Lebe E, Baka M, Yavaşoğlu A, Aktuğ H, Ateş U, Uyanikgil Y.
    Pharmacology; 2004 Oct; 72(2):113-20. PubMed ID: 15331917
    [Abstract] [Full Text] [Related]

  • 25. The effect of different preparations of nasal decongestants on ciliary beat frequency in vitro.
    Deitmer T, Scheffler R.
    Rhinology; 1993 Dec; 31(4):151-3. PubMed ID: 7511251
    [Abstract] [Full Text] [Related]

  • 26. Rapid-onset intranasal delivery of metoclopramide hydrochloride. Part I. Influence of formulation variables on drug absorption in anesthetized rats.
    Zaki NM, Awad GA, Mortada ND, Abd ElHady SS.
    Int J Pharm; 2006 Dec 11; 327(1-2):89-96. PubMed ID: 16942844
    [Abstract] [Full Text] [Related]

  • 27. Negative side of nasal saline sprays: they can be harmful.
    Berry YJ.
    Arch Otolaryngol Head Neck Surg; 2003 Dec 11; 129(12):1352; author reply 1352. PubMed ID: 14676174
    [No Abstract] [Full Text] [Related]

  • 28. The antimicrobial effectiveness of some preservatives in inactivated human vaccines.
    Hekkens FE, Polak-Vogelzang AA, Kreeftenberg JG.
    J Biol Stand; 1981 Dec 11; 9(3):277-85. PubMed ID: 6792203
    [No Abstract] [Full Text] [Related]

  • 29. A recombinant P4 protein of Haemophilus influenzae induces specific immune responses biologically active against nasopharyngeal colonization in mice after intranasal immunization.
    Hotomi M, Ikeda Y, Suzumoto M, Yamauchi K, Green BA, Zlotnick G, Billal DS, Shimada J, Fujihara K, Yamanaka N.
    Vaccine; 2005 Jan 26; 23(10):1294-300. PubMed ID: 15652672
    [Abstract] [Full Text] [Related]

  • 30. [Test of preservation on decoction of medicinal herbs].
    Ge YX.
    Zhong Yao Tong Bao; 1982 Jan 26; 7(6):20-1. PubMed ID: 6218915
    [No Abstract] [Full Text] [Related]

  • 31. [Comparative characteristics of blood prepared with No. 12 and 76 preservatives].
    Oldurova SV, Suvorova LA, Sukhova AG, Golubeva VL, Manueva GN.
    Probl Gematol Pereliv Krovi; 1975 Jan 26; 20(1):40-3. PubMed ID: 1110962
    [No Abstract] [Full Text] [Related]

  • 32. [Laboratory-clinical substantiation of permissibility of blood preparation on preservatives without levomycetin].
    Petrov MM, Fedorovskaia EA, Kushko OV, Babiĭ ZN, Petrushov VN.
    Probl Gematol Pereliv Krovi; 1978 May 26; 23(5):55-7. PubMed ID: 674150
    [No Abstract] [Full Text] [Related]

  • 33. Studies on the evaluation of preservative efficacy. I. The determination of antimicrobial characteristics of phenol.
    Karabit MS, Juneskans OT, Lundgren P.
    Acta Pharm Suec; 1985 May 26; 22(5):281-90. PubMed ID: 4090999
    [No Abstract] [Full Text] [Related]

  • 34. Induction of immune responses and prevention of alveolar bone loss by intranasal administration of mice with Porphyromonas gingivalis fimbriae and recombinant cholera toxin B subunit.
    Takahashi Y, Kumada H, Hamada N, Haishima Y, Ozono S, Isaka M, Yasuda Y, Tochikubo K, Umemoto T.
    Oral Microbiol Immunol; 2007 Dec 26; 22(6):374-80. PubMed ID: 17949339
    [Abstract] [Full Text] [Related]

  • 35. Safety review of benzalkonium chloride used as a preservative in intranasal solutions: an overview of conflicting data and opinions.
    Marple B, Roland P, Benninger M.
    Otolaryngol Head Neck Surg; 2004 Jan 26; 130(1):131-41. PubMed ID: 14726922
    [Abstract] [Full Text] [Related]

  • 36. In vitro effects of preservatives in nasal sprays on human nasal epithelial cells.
    Ho CY, Wu MC, Lan MY, Tan CT, Yang AH.
    Am J Rhinol; 2008 Jan 26; 22(2):125-9. PubMed ID: 18416966
    [Abstract] [Full Text] [Related]

  • 37. [The antimicrobial effectiveness of various preservatives, alone or in combination, in creams and hydrophilic gels. I. Choice of preservatives].
    Favet J, Griffiths W, Amacker PA, Schorer E.
    Pharm Acta Helv; 1983 Jan 26; 58(7):178-88. PubMed ID: 6889407
    [No Abstract] [Full Text] [Related]

  • 38. Alternatives to Benzalkonium Chloride containing nasal preparations.
    Qureshi AA, Nilssen E.
    Clin Otolaryngol; 2015 Aug 26; 40(4):400-1. PubMed ID: 26179693
    [No Abstract] [Full Text] [Related]

  • 39. Influence of (ethoxy)5 octyl phenol on the antibacterial properties of preservatives [proceedings].
    Nadir MT, Allwood MC.
    J Pharm Pharmacol; 1977 Dec 26; 29 Suppl():67P. PubMed ID: 22700
    [No Abstract] [Full Text] [Related]

  • 40. [The effects of preservatives in hydrogels].
    Hung C, Neumann S, Dittgen M.
    Pharmazie; 1986 Aug 26; 41(8):601-2. PubMed ID: 3786389
    [No Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 6.